Sharing Management Issues through Department Head Meetings and Manufacturing and Sales Division Meetings
First written in FY2016. 3 of 5 entries say "Restated". Latest entry: FY2025.
84 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「As of the date of filing the Annual Securities Report (25 June 2025), the Management Meeting was chaired by President and Representative Director Kageyama Yoji (景山 洋二) and comprised Directors Nakajima Takashi (中島 崇), Horinouchi Hiroshi (堀之内 広) and Nakajima Fumihiro (中島 史博). It deliberates on important management matters and reviews the status of business execution.」
Deliberation of important matters and review of business execution centered on the Management Meeting is being continued, including its members. - FY2022RestatedAnnual report
「A Management Meeting has been established to accelerate management decision-making across the Company. As of the date of filing the Annual Securities Report, the Management Meeting was chaired by President and Representative Director Kageyama Yoji (景山 洋二) and comprised Directors Nakajima Takashi (中島 崇), Horinouchi Hiroshi (堀之内 広) and Nakajima Fumihiro (中島 史博). It deliberates on important management matters and reviews the status of business execution.」
The Management Meeting described in FY2021 has been continued in the annual report, including its members and role. - FY2021ReframedAnnual report
「A Management Meeting has been established to accelerate management decision-making across the Company. As of the date of filing the Annual Securities Report, the Management Meeting was chaired by President and Representative Director Kageyama Yoji (景山 洋二) and comprised Directors Nakajima Takashi (中島 崇), Horinouchi Hiroshi (堀之内 広) and Nakajima Fumihiro (中島 史博). It deliberates on important management matters and reviews the status of business execution.」
In addition to the previous explanation centered on the Division Heads’ Meeting, it describes the Management Meeting as a formal forum for decision-making and reviewing business execution. - FY2018RestatedAnnual report
「The Division Heads’ Meeting, comprising the representative directors, directors in charge and division heads in charge, among others, is held monthly to deliberate on operational issues and review the status of business execution. In addition, operational coordination between 東郷メディキット㈱, the Company’s manufacturing subsidiary, and the Company, its sales company, is an important issue for business execution. Meetings of the heads of the manufacturing and sales departments are therefore held regularly to discuss management issues facing the Group.」
The monthly Division Heads’ Meeting and regular manufacturing and sales department meetings are being continued as mechanisms for decision-making and coordination across the Group. - FY2016First statedAnnual report
「To accelerate management decision-making across the Company, the Division Heads’ Meeting, comprising the representative directors, directors in charge and division heads in charge, among others, is held monthly to deliberate on operational issues and review the status of business execution. In addition, operational coordination between 東郷メディキット㈱, the Group’s manufacturing subsidiary, and the Company, its sales company, is an important issue for business execution. Meetings of the heads of the manufacturing and sales departments are therefore held regularly to discuss management issues facing the Group.」
The monthly Division Heads’ Meeting and regular manufacturing and sales department meetings serve as mechanisms for decision-making and coordination.